Summary Tenascin, a novel six-armed extracellular matrix glycoprotein, was immunohistochemically examined in the human normal adult colon, and colonic neoplasms such as tubular adenomas, primary and metastatic adenocarcinomas. In contrast to previous reports, tenascin was hardly detectable in the normal adult colons, being predominantly localised in the fibrous stroma surrounding the glandular epithelia of the neoplastic lesions. The neoplastic cells themselves were totally negative for tenascin expression. Both the tubular adenoma tissues and the superficial layer of well-differentiated adenocarcinomas in general were intensely reactive to tenascin antibody, and the staining intensity increased as the adenoma became more atypical in cases of tubular adenomas. By pretreatment of the paraffin-embedded tissue sections with pepsin, the distribution of tenascin was often intensified considerably and distinct localisation was more clearly demonstrated in the colonic tumour tissues. Tenascin was also biochemically purified from human invasive colonic carcinomas, and this cancerous tissue tenascin was compared with that extracted from a human umbilical cord fibroblast cell line in terms of molecular heterogeneity. Two major isoforms of the purified tenascin from colonic cancer tissues were found to have relative molecular masses of 250 kD and 190 kD, which were almost identical to those of human foetal fibroblast tenascin glycoproteins. In addition, several lower molecular weight isoforms were frequently detectable in the cancerous tissues, which might represent immuno-reactive tenascin isoforms proteolytically digested in human colonic carcinomas in vivo.
Tenascin (TN) (Chiquet-Ehrismann et al., 1986 ) is an extracellular matrix (ECM) glycoprotein with a unique six-armed macromolecular structure and an unusually restricted tissue distribution. During foetal development, TN is produced by mesenchyme adjacent to actively growing epithelia, and in adult tissues, it is found in the stroma of benign and malignant tumours (Chiquet-Ehrismann et al., 1986; Mackie et al., 1987) . These findings suggest that TN may be an oncofoetal protein that plays an important role in cell-to-cell communication in the process of proliferation and migration, and characterises embryonic morphogenesis as well as tumour cell invasion and metastasis. We previously demonstrated that some membrane-associated enzymes such as alkaline phosphatase and 5'-nucleotidase were produced by stromal cells of chemical carcinogen-induced gastric adenocarcinomas in rats (Hirota et al., 1989a (Hirota et al., , 1989b Sakai et al., 1991) , and these enzymes were sometimes co-expressed with TN (N. Hirota and T. Sakai, unpublished work) . TN is also the multifunctional glycoprotein, participating in cell adhesion and repulsion, guidance along cell migration pathways, epithelial cell shedding from surfaces, demarcation of tissue boundaries, promotion of cell growth, and hemagglutination (Erickson & Lightner, 1988; Erickson & Bourdon, 1989) . In a previous study, we demonstrated that TN purified from human foetal umbilical cord fibroblast cultures was composed of two kinds of isoforms with relative molecular masses of 250 kD and 190 kD (Oike et al., 1990) . Thus, considering these reports together, the temporal, spatial distribution and multifunctional roles of TN molecule raise an important biological question. Is TN from human cancerous tissues different from that derived from human normal foetal stromal cells such as fibroblasts? In the present study, tissue distribution of TN from colonic tissues was investigated by immunohistochemical staining. We also examined molecular differences between TNs from various colon cancers with reference to their histological patterns. Here we report that major TN isoforms from well-and moderately-differentiated adenocarcinomas were found to have relative molecular weights identical to those of human normal foetal fibroblasts, and that TN from poorly-differentiated and mucinous types of colon cancers contain some immuno-reactive isoforms proteolytically digested in human colonic carcinomas in vivo.
Materials and methods

Antibodies
The following primary antibody preparations were used in this study: (1) monoclonal rat antibody (RCB 1, IgG2a isotype) to TN purified from human umbilical cord fibroblast cell line, HUCF-p2 (Oike et al., 1990) ; and (2) polycloncal rabbit antibody to fibronectin (FN) (Organon Teknika N.V., West Chester, NY).
Immunohistochemistry for TN Neoplastic and non-neoplastic samples were derived from surgically resected materials. They included 15 normal colons, eight hyperplastic polyps, 20 adenomas, 30 adenocarcinomas (26 well-or moderately-differentiated adenocarcinomas, including metastatic lesions of lymph-nodes, and four poorly-differentiated adenocarcinomas), and eight mucinous carcinomas. The materials were immediately fixed in 10% buffered formalin, embedded in paraffin, and sectioned at a thickness of 3 ism. Sections were deparaffinised in xylene, and rehydrated in a graded ethanol series (100-50%) followed by a rinse in water. Then they were pretreated with 0.4% pepsin (Sigma Chem. Co., St. Louis) in 0.01 M HCI for 2 h at 37'C, and briefly rinsed in water. In order to inactivate endogenous peroxidase enzyme, sections were immersed in methanol containing 0.3% hydrogen peroxide for 30 min at room temperature. After three 10 min washes in phosphate-buffered saline (PBS), sections were incubated in PBS containing 10% normal goat serum, pH 7.4 for 30 min to block nonspecific protein binding. Slides were washed again in PBS, and the primary antibody was applied to each section overnight at 4°C. Monoclonal rat antibody to TN was diluted 1:100. Normal rat serum was used as negative control primary antibody. After incubation in primary antibody, slides were washed three times in PBS, and a secondary antibody layer composed of biotinylated goat anti-rat IgG (diluted 1:500) (Organon Teknika N.V., West Chester, NY) was applied for 40 min at room temperature. Slides were washed again, and treated with horseradish peroxidase-conjugated avidin-biotin complex (ABC) (DAKOPATTS, A/S., Denmark) for 40 min at room temperature. A final wash in PBS was performed, and slides were incubated in a freshly prepared chromogen solution containing 0.1% 3,3'-diaminobenzidine tetrahydrochloride (Dojindo Lab., Japan) and 0.02% hydrogen perox- (Smith et al., 1985) , and immunoreactivity with both TN and FN antibodies was examined by immunoblotting.
Gelatin affinity gel chromatography In order to remove FN from TN-enriched fractions, gelatin affinity gel chromatography was performed by the method described previously (Oike et al., 1990) , with a slight mpdification. Briefly, TNenriched fractions were concentrated to 1/10 volume with CentriCell (Polyscience, Inc., Warrington), and then dialysed against 100 volumes of 0.5 M urea, 0.15 M NaCl, 50mM Tris-HCI pH 7.4, 2 mM PMSF and 0.2% (w/v) CHAPS for overnight at 4°C. The dialysate was incubated with gelatin Sepharose 4B gel (Pharmacia LKB Biotech., Sweden) (1 ml gel for 1 mg protein) for overnight at 4°C with rotating at 100 r.p.m. The gel-containing solution was poured into a glass column (1 x 10 cm), and washed with 5 bed volumes of ice cold dialysed buffer. Fractions that passed through the column were collected and concentrated to 1/10 volume with CentriCell, and then dialysed against 100 volumes of gel filtration buffer without 0.15 M NaCl for overnight at 4°C.
Ion exchange high performance liquid chromatography DEAE-5PW column (1 cm x 5 cm, Toso, Japan) was equilibrated with 4 M urea, 50 mM Tris-HCl pH 8.0 at a flow rate of 0.5 ml min-'. Samples were loaded and elution was achieved with an ascending gradient of 4 M urea, 1 M NaCl, 50 mM Tris-HCl pH 8.0: 0-40% in 40 min and 40-100% in 10 min. The elution was monitored by absorption at 280 nm. The distribution of immunogenicity for TN was determined by immunoblotting.
SDS-PAGE and immunoblotting Reduced samples were prepared as follows: samples (10 mg as protein) were dissolved in 10 yl of 50 mM Tris-HCl pH 6.8, 1% (v/v) 2-mercaptoethanol, 2% (w/v) sodium dodecyl sulfate, 20% (w/v) glycerol, 0.04% (w/v) bromophenol blue and were heated at 100°C for 3 min. The electrophoresis unit was a model of the vertical slab gel electrophoresis (Dai-ichi Pure Chem., Japan). Samples were applied to 4-20% (w/v) sodium dodecyl sulfate polyacrylamide gradient gels. Electrophoresis (Laemmli, 1970) was at 10 mA for 10 min to load samples then 30 mA until the tracking dye was near the end of the gel. Immunoblotting was performed by the following procedure of Towbin et al. (1979) . TN bands on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) were transferred onto Immobilon-P transfer membrane (Millipore Corp., Bedford, MA) with Trans-Blot Cell (Bio-Rad Lab., Richmond, CA) at 30 V for overnight at 4°C. The membrane was washed three times in PBS containing 0.5% bovine serum albumin (BSA, fraction V) (Sigma Chem. Co., St. Louis) and 0.1% polyoxyethylene sorbitan monolaurate (Tween 20). In order to block nonspecific protein binding, the membrane was incubated in PBS containing 3% normal goat serum, 0.5% BSA and 0.1% Tween 20 for 30 min at room temperature, and then incubated in primary antibody overnight at 4°C. Monoclonal rat antibody to TN was diluted 1:200 in PBS containing 3% BSA and 0.05% Tween 20. After incubation in primary antibody, the membrane was washed three times, and incubated in a secondary antibody composed of peroxidase-conjugated goat anti-rat IgG (diluted 1:400) (Organon Teknika, N.V., West Chester, NY) for 2.5 h at room temperature. For visualisation of immunoreactive bands, the membrane was incubated in a freshly prepared chromogen solution containing 3,3'-diaminobenzidine tetrahydrochloride plus cobalt chloride (Sigma Chem. Co., St. Louis), and 0.02% hydrogen peroxide in 50 mM Tris-HCl pH 7.6.
Results
Immunohistochemical localisation of TN in human normal adult colons and colonic neoplastic lesions Expression of TN was found to be almost negative in the normal adult colonic mucosa, as shown in Figure 1 . In the region of subepithelial lamina propria and muscularis mu- cosa with inflammatory or regenerative changes, only minimal expression, if any, was detectable. As shown in Figure 2 , immunoreactivity of TN was found to be localised preferentially in the fibrous stroma surrounding the glandular epithelia of the neoplastic lesions. In general, the most intense reaction for TN antibody was demonstrated in the fibrous stroma of both tubular adenomas and the superficial layer of well-differentiated adenocarcinomas (Figure 2a-c) . In particular, in cases of tubular adenoma, the staining intensity increased as the adenoma a b became more atypical in contrast to almost completely negative immunoreactivity in the hyperplastic areas (Figure  2a and b) . Hyperplastic polyps were almost free of immunoreactivity except for those showing inflammatory changes (data not shown). The typical staining pattern of TN was demonstrated in the tubules of adenocarcinomas, outlining the border of the tubules (Figure 2d ). TN staining was also invariably seen in the muscularis mucosa, the wall of submucosal blood vessels including arterioles, and the muscularis propria in addition to the fibrous stroma within the neoplastic lesions (Figure 3a) . Moreover, the non-neoplastic mucosae near cancerous lesions showed the same positive reactions (Figure 3b ). Those positive reactions gradually became weaker however, as the non-neoplastic mucosae became more distant from the cancerous lesions.
The intensity of TN immunostaining in the stroma characteristic of invasive well-and moderately-differentiated adenocarcinomas varied from area to area, and both the TN staining pattern and its stromal localisation were not dependent on the degree of tumour differentiation. However, in poorly-differentiated adenocarcinomas, which were rich in fibrous stroma, the reaction with TN antibody was almost negative (Figure 3c ). In contrast, there was a prominent positive reaction with TN antibody in the stroma, including the capsule adjacent to the tubules, and the wall of vessels in the metastatic foci of the lymph-nodes of well-or moderately-differentiated adenocarcinomas (Figure 3d ). No significant difference in the staining pattern was found between primary tumours and secondary lesions in lymphnodes. The results of these immunohistochemical studies are summarised in Table II By pretreatment of the paraffin-embedded tissue sections with pepsin, the distribution of TN was considerably intensified and the distinct localisation of TN was more clearly demonstrated in colonic tumour tissues (Figure 4a and b) . Table I shows eight cases of advanced colonic carcinomas, the TN of which was extracted and purified. Two typical gel filtration profiles on Sepharose CL-4B of ECM glycoproteins were shown in Figure 5 (5a, case 1: moderately-differentiated adenocarcinoma; and Sb, case 6: mucinous carcinoma). The protein profile was determined by BCA assay and the immunoreactivity with both TN and FN antibodies was examined by immunoblotting. The peak fraction of TN preceded that of FN (Figure 5 ), and the contents of both TN and FN in the cases of well-and moderately-differentiated adenocarcinomas (cases 1-5) were definitely higher than those of the mucinous and poorly-differentiated adenocarcinomas (cases 6-8) (data not shown). In each case, TNenriched fractions termed Fraction A (Figure 5a ), were collected, concentrated with CentriCell. Gelatin Sepharose 4B affinity chromatography was performed in order to remove FN from Fraction A. Then the fraction was applied to DEAE-5PW ion-exchange HPLC column. Three major peaks (termed Fractions I, II and III) were found on the elution pattern in the case 1 (Figure 6a ). Immunoblotting for TN demonstrated that Fraction I was the most TN-enriched peak, and the major protein bands in Fraction I were found to have apparent molecular weights of 250 and 190 kD. In addition, some lower-molecular weight bands were observed (Figure 6b ). Fraction I was collected, concentrated and analysed for immunogenicity by immunoblotting. As shown in Figure (Oike et al., 1990; Natali et al., 1991) . This discrepancy might be explained as follows: the monoclonal antibody to human TN used by Natali et al. (1991) (Mackie et al., 1988; , Murakami et al., 1989) , and our present data also sometimes demonstrated weak positive expression in the inflammatory and regenerative mucosae. As a general feature, most interstitial fibroblasts express no detectable levels of TN, suggesting that, in normal conditions, its synthesis is shut off in these cells (Erickson & Bourdon, 1988; Natali et al., 1991 (Figure 4a and b) . It is known that the basement membrane zone antigens, which are ECM components, are selectively enhanced by pretreatment with pepsin in the formalin-fixed and paraffin-embedded sections, whereas pretreatment by other proteases such as trypsin and collagenase is ineffective (Barsky et al., 1984) . Our present studies also demonstrated that pretreatment by pepsin in the formalin-fixed, paraffin-embedded sections was an effective method to unmask the TN antigenic sites. This enables us to investigate various lesions retrospectively, including rare cases of many diseased tissues embedded for years in paraffin.
Comparison of TNs extractedfrom human colonic carcinomas
There is a correlation in the content between TN and FN in each case in gel filtration, and the content of TN is also considered to represent the histochemical reactivity of TN in the stroma surrounding adenocarcinoma cells. In fact, the intensity of TN immunostaining in invasive adenocarcinomas seemed to reflect the content of TN in the purified fractions. The two major molecular isoforms of purified TN from advanced human colon cancers w'ere composed of 250 kD and 190 kD under reducing conditions, which were identical to those of human foetal fibroblast (Oike et al., 1990) . This may suggest identity of the protein species and may justify consideration of TN as an oncofoetal antigen. Several other lower molecular weight forms, which ranged from 130 kD to 40 kD, were also identified as the immuno-reactive TN in the colonic carcinomas. These lower molecular weight molecules may be proteolytically-digested TN isoforms or alternativelyspliced or post-translationally-modified forms. There is a well established concept that tumour invasion and metastasis require enzymatic degradation of the host interstitial matrix.
The dissociation of the tumour cells depends on changes both in the ECM surrounding the primary tumour and in the adhesive property of the tumour cells themselves (Liotta, 1986; Tryggvason et al., 1987; Hart et al., 1989) . It is also known that an advancing front of invasive tumour cells can also induce secretion of hydrolytic enzymes from their adjacent non-tumour host cells (Moscatelli & Rifkin, 1988; Blood & Zetter, 1990) . Recently, Basset et al. (1990) suggested that stromelysin-3 may be an enzyme which degrades ECM in cancers to play an important part in progression of epithelial malignancy, and raised the possibility that stromelysin-3 acts on TN during the invasive phase of cancer. If this is the case, the decreased content of TN in poorly-differentiated adenocarcinomas, including mucinous carcinomas of colon (cases 6-8), might result from the high enzyme activity in these cancer tissues to digest the TN molecules. On the other hand, as demonstrated in chicken (Pearson et al., 1988) , mouse (Weller et al., 1991; Saga et al., 1991) and human (Siri et al., 1991) TN molecules, there are several isoforms derived from alternative splicing of precursor mRNA of the FN type III-like domain or from post-translational modification of the polypeptide with N-linked carbohydrate moieties. Further studies remain to be done to determine the pathobiological significance of the interaction between epithelial cells and surrounding ECM, especially TN during colonic carcinogenesis, and proliferation or infiltration of carcinoma cells of the colon.
